$3.54
1.87%
Nasdaq, Jul 11, 10:00 pm CET
ISIN
US36322Q1076
Symbol
GLTO
Sector
Industry

Galecto Inc Stock price

$3.54
+0.15 4.28% 1M
-1.56 30.55% 6M
-1.12 23.98% YTD
-9.34 72.55% 1Y
-44.22 92.60% 3Y
-371.47 99.06% 5Y
-371.47 99.06% 10Y
-371.47 99.06% 20Y
Nasdaq, Closing price Fri, Jul 11 2025
+0.07 1.87%
ISIN
US36322Q1076
Symbol
GLTO
Sector
Industry

Key metrics

Basic
Market capitalization
$4.7m
Enterprise Value
$-7.3m
Net debt
positive
Cash
$11.9m
Shares outstanding
1.3m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
0.5
P/B
0.3
Financial Health
Equity Ratio
92.4%
Return on Equity
-135.4%
ROCE
-138.3%
ROIC
-788.6%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-18.9m | $-63.6m
EBIT
$-19.1m | $-24.2m
Net Income
$-18.5m | $-14.9m
Free Cash Flow
$-15.1m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
40.7% | -280.7%
EBIT
40.5% | -43.2%
Net Income
40.0% | 30.6%
Free Cash Flow
55.1%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-14.0
FCF per Share
$-11.5
Short interest
3.5%
Employees
13
Rev per Employee
$0.0
Show more

Is Galecto Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,006 stocks worldwide.

Galecto Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Galecto Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Galecto Inc forecast:

Hold
50%
Sell
50%

Financial data from Galecto Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 9.14 9.14
29% 29%
-
- Research and Development Expense 4.61 4.61
71% 71%
-
-19 -19
41% 41%
-
- Depreciation and Amortization 0.18 0.18
28% 28%
-
EBIT (Operating Income) EBIT -19 -19
41% 41%
-
Net Profit -19 -19
40% 40%
-

In millions USD.

Don't miss a Thing! We will send you all news about Galecto Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Galecto Inc Stock News

Neutral
GlobeNewsWire
2 months ago
BOSTON, May 08, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for oncology and liver diseases, announced its operating and financial results for the quarter ended March 31, 2025.
Neutral
GlobeNewsWire
4 months ago
BOSTON, March 19, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and fibrosis, today announced its operating and financial results for the quarter and year ended December 31, 2024.
Neutral
GlobeNewsWire
5 months ago
BOSTON, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company focused on the development of novel treatments for cancer and severe liver diseases, today announced that the Company management team will participate in the following upcoming investor conferences:

Company Profile

Galecto, Inc. operates as a clinical-stage biotechnology company developing therapeutics which are designed to target the biological processes to treat fibrotic and related diseases including cancer. Its product portfolio includes GB0139, GB1211, GB2064, and GB1211. The company was founded by Ulf Nilsson, Hakon Leffler, Tariq Sethi, and Hans T. Schambye in 2011 and is headquartered in Copenhagen, Denmark.

Head office United States
CEO Hans Schambye
Employees 13
Founded 2011
Website galecto.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today